Currie Graeme Martin bought KTTA
March 1, 2024 · Form 4 insider transaction
Currie Graeme Martin bought 5,938 shares of Pasithea Therapeutics Corp. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,938
Price
$0.00
Total value
N/A
InsiderCurrie Graeme Martin
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 1, 2024
Filing dateMarch 1, 2024
Shares owned after5,938
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The Option fully vested upon issuance and became exercisable on March 1, 2024.